TEVA CIK: 818686

Teva Pharmaceutical Industries Ltd. ADR

  • Israel
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY23
FY23
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
billions USD
FY23:
–
FY23:
–
FY23:
12.5
FY24:
12.6
FY25:
13.9
(positive)
Change from FY23 to FY25
billions USD
FY23:
–
FY23:
–
FY23:
31.0
FY24:
26.8
FY25:
26.8
Total assets
Change from FY23 to FY25
billions USD
FY23:
43.1
FY23:
42.1
FY23:
43.5
FY24:
39.3
FY25:
40.7

Liabilities & Equity

(negative)
Change from FY23 to FY25
billions USD
FY23:
–
FY23:
–
FY23:
12.2
FY24:
12.8
FY25:
13.5
(negative)
Change from FY23 to FY25
billions USD
FY23:
–
FY23:
–
FY23:
23.1
FY24:
20.8
FY25:
19.4
(positive)
Change from FY23 to FY25
billions USD
FY23:
7.59
FY23:
7.39
FY23:
7.51
FY24:
5.37
FY25:
7.91
Total liabilities & equity
Change from FY23 to FY25
billions USD
FY23:
43.1
FY23:
42.1
FY23:
–
FY24:
–
FY25:
40.7

All amounts in billions USD Data source:SEC EDGAR